Resources & Guides
Educational content about GLP-1 medications, pharmacokinetics, and optimizing your treatment journey.
GLP-1 Medication Hubs
Comprehensive guides for each GLP-1 medication—dosing protocols, clinical trial data, microdosing strategies, and our free calculators.
Semaglutide Guide
Ozempic & Wegovy: GLP-1 receptor agonist. ~15% weight loss, 7-day half-life. FDA-approved for diabetes and weight management.
Tirzepatide Guide
Mounjaro & Zepbound: Dual GLP-1/GIP agonist. ~21% weight loss, 5-day half-life. The first dual-agonist approved by FDA.
Retatrutide Guide
Triple GLP-1/GIP/Glucagon agonist. ~24% weight loss in trials, 6-day half-life. Expected FDA approval 2027.
Educational Content
Semaglutide Reconstitution Chart: BAC Water, IU, and Vial Sizes (2026)
articleThe screenshot-ready semaglutide reconstitution chart. Every common vial size and BAC water volume crossed with the full Wegovy titration, converted to insulin syringe units.
Tirzepatide Reconstitution Chart: 5mg to 60mg Vials in Units
articleThe screenshot-ready tirzepatide reconstitution chart. Every vial size (5mg to 60mg) crossed with every BAC water volume and every titration dose, converted to insulin syringe units.
Retatrutide Reconstitution Chart: Every Vial, Every Dose in IU
articleThe screenshot-ready retatrutide reconstitution chart. All six common vial sizes (5mg to 60mg) crossed with every BAC water volume and every titration dose, converted to insulin syringe units.